273 related articles for article (PubMed ID: 10861597)
1. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
Thanou M; Verhoef JC; Marbach P; Junginger HE
J Pharm Sci; 2000 Jul; 89(7):951-7. PubMed ID: 10861597
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
3. Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.
Thanou M; Verhoef JC; Verheijden JH; Junginger HE
Pharm Res; 2001 Jun; 18(6):823-8. PubMed ID: 11474787
[TBL] [Abstract][Full Text] [Related]
4. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
5. Chitosan and its derivatives as intestinal absorption enhancers.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Oct; 50 Suppl 1():S91-101. PubMed ID: 11576697
[TBL] [Abstract][Full Text] [Related]
6. N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats).
Thanou M; Florea BI; Langemeÿer MW; Verhoef JC; Junginger HE
Pharm Res; 2000 Jan; 17(1):27-31. PubMed ID: 10714604
[TBL] [Abstract][Full Text] [Related]
7. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer AG; Verhoef JC; Junginger HE
J Control Release; 1998 Jan; 51(1):35-46. PubMed ID: 9685902
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation.
Florea BI; Thanou M; Junginger HE; Borchard G
J Control Release; 2006 Jan; 110(2):353-361. PubMed ID: 16269199
[TBL] [Abstract][Full Text] [Related]
10. Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luessen HL; de Boer BG; Verhoef JC; Junginger HE
Eur J Pharm Biopharm; 1999 May; 47(3):269-74. PubMed ID: 10382111
[TBL] [Abstract][Full Text] [Related]
11. Oral drug absorption enhancement by chitosan and its derivatives.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Nov; 52(2):117-26. PubMed ID: 11718935
[TBL] [Abstract][Full Text] [Related]
12. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
13. N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells.
Hamman JH; Schultz CM; Kotzé AF
Drug Dev Ind Pharm; 2003 Feb; 29(2):161-72. PubMed ID: 12648013
[TBL] [Abstract][Full Text] [Related]
14. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
15. Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation.
Jonker C; Hamman JH; Kotzé AF
Int J Pharm; 2002 May; 238(1-2):205-13. PubMed ID: 11996824
[TBL] [Abstract][Full Text] [Related]
16. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.
Sahni JK; Chopra S; Ahmad FJ; Khar RK
J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113
[TBL] [Abstract][Full Text] [Related]
17. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
du Plessis LH; Kotzé AF; Junginger HE
Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
[TBL] [Abstract][Full Text] [Related]
18. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.
Thanou MM; Kotzé AF; Scharringhausen T; Luessen HL; de Boer AG; Verhoef JC; Junginger HE
J Control Release; 2000 Feb; 64(1-3):15-25. PubMed ID: 10640642
[TBL] [Abstract][Full Text] [Related]
19. Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Boselli C; Caramella C
AAPS PharmSciTech; 2010 Mar; 11(1):362-71. PubMed ID: 20232266
[TBL] [Abstract][Full Text] [Related]
20. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
